Methotrexate

Two-week methotrexate discontinuation in patients with rheumatoid arthritis vaccinated with inactivated SARS-CoV-2 vaccine: a randomised clinical trial
Carlo Scognamiglio Renner Araujo, Ana Cristina Medeiros-Ribeiro, Carla G S Saad, Karina Rossi Bonfiglioli, Diogo Souza Domiciano, Andrea Yukie Shimabuco, Matheus Santos Rodrigues Silva, Emily Figueiredo Neves Yuki, Sandra Gofinet Pasoto, Tatiana Pedrosa, Leonard de Vinci Kanda Kupa, Gioanna Zou, Rosa M R Pereira, Clóvis Artur Silva, Nádia Emi Aikawa, Eloisa Bonfa

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 889-897; DOI: 10.1136/annrheumdis-2021-221916
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dennis Scheicht

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e89; DOI: 10.1136/annrheumdis-2020-217041
Response to: ‘Error in the dosage of methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis’ by Scheicht
Chetan B Mukhtyar, Bernhard Hellmich

Annals of the Rheumatic Diseases Jun 2022, 81 (6) e90; DOI: 10.1136/annrheumdis-2020-217063
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis
Lotte van Ouwerkerk, Andriko Palmowski, Isabell S Nevins, Frank Buttgereit, Patrick Verschueren, Josef S Smolen, Robert BM Landewé, Johannes JW Bijlsma, Andreas Kerschbaumer, René Westhovens, Tom WJ Huizinga, Cornelia F Allaart, Sytske Anne Bergstra

Annals of the Rheumatic Diseases Jul 2022, 81 (7) 937-943; DOI: 10.1136/annrheumdis-2022-222338
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
Victoria Furer, Tali Eviatar, Devy Zisman, Hagit Peleg, Daphna Paran, David Levartovsky, Michael Zisapel, Ofir Elalouf, Ilana Kaufman, Roni Meidan, Adi Broyde, Ari Polachek, Jonathan Wollman, Ira Litinsky, Katya Meridor, Hila Nochomovitz, Adi Silberman, Dana Rosenberg, Joy Feld, Amir Haddad, Tal Gazzit, Muna Elias, Nizar Higazi, Fadi Kharouf, Gabi Shefer, Orly Sharon, Sara Pel, Sharon Nevo, Ori Elkayam

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1330-1338; DOI: 10.1136/annrheumdis-2021-220647
Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis
Andreas Kerschbaumer, Zaïda Iasha Rivai, Josef S Smolen, Daniel Aletaha

Annals of the Rheumatic Diseases Oct 2022, 81 (10) 1374-1378; DOI: 10.1136/annrheumdis-2021-221807
Baricitinib further enhances disease-modifying effects by uncoupling the link between disease activity and joint structural progression in patients with rheumatoid arthritis
Pedro Lopez-Romero, Inmaculada de la Torre, Ewa Haladyj, Daniel Aletaha, Josef S Smolen

Annals of the Rheumatic Diseases May 2022, 81 (5) 622-631; DOI: 10.1136/annrheumdis-2021-221323
Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases
Jerome Hadjadj, Delphine Planas, Amani Ouedrani, Solene Buffier, Laure Delage, Yann Nguyen, Timothée Bruel, Marie-Claude Stolzenberg, Isabelle Staropoli, Natalia Ermak, Laure Macraigne, Caroline Morbieu, Soledad Henriquez, David Veyer, Hélène Péré, Marion Casadevall, Luc Mouthon, Frederic Rieux-Laucat, Lucienne Chatenoud, Olivier Schwartz, Benjamin Terrier

Annals of the Rheumatic Diseases May 2022, 81 (5) 720-728; DOI: 10.1136/annrheumdis-2021-221508
Response to: ‘Tapering antirheumatic drugs in a resource-poor setting: real-world evidence’ by Haroon et al
Elise van Mulligen, Pascal H P de Jong

Annals of the Rheumatic Diseases Oct 2022, 81 (10) e209; DOI: 10.1136/annrheumdis-2020-218731
Methotrexate prolongs TNF inhibitor survival, but only in autoantibody-positive rheumatoid arthritis: a validation study
Elise van Mulligen, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong

Annals of the Rheumatic Diseases Oct 2023, 82 (10) e217; DOI: 10.1136/annrheumdis-2020-219499

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages